Webinar – Do I Really Have No Evidence of Disease?

This webinar is put on by Colorectal Cancer Canada

Join us on Thursday, March 14th, 7:00pm-8:00pm (EST) for a webinar with Dr. Minetta Liu and Dr. Michael Raphael, where we will explore key topics surrounding circulating tumour DNA (ctDNA) and the Signatera™ test. This session will be moderated by Barry Stein, President & CEO of Colorectal Cancer Canada.

Is my treatment working? Do I really have no evidence of disease?

If you have been diagnosed with colorectal cancer (CRC), you likely have many lingering questions and anxiety about cancer recurrence or whether your treatment is effective. To reduce anxiety and answer these important questions, many patients are turning to circulating tumour DNA (ctDNA) tests. ctDNA (also known as tumour-specific DNA), are fragments of tumour DNA found in the blood and can be measured to help determine: (1) signs of cancer remaining in the body, (2) if treatment (e.g., chemotherapy) is working; (3) whether the cancer is recurring (cancer recurrence).

To measure ctDNA, Natera has developed their Signatera™ test, which is a personalized, tumour-informed test – optimized to detect ctDNA. Signatera™ can identify whether cancer is still present or recurring earlier than traditional care tools.

This webinar will provide information on the Signatera™ test, case studies and patient experiences in Canada. There will be a panel discussion followed by a Q&A session.